[Pharmwaste] FW: EPA Continues Work to Understand Potential Impacts of Pharmaceuticals in Water

Sierra Fletcher sierra at productstewardship.us
Tue Aug 12 11:45:41 EDT 2008


Sent: Monday, August 11, 2008 2:14 PM
Subject: EPA Continues Work to Understand Potential Impacts of
Pharmaceuticals in Water

 

EPA Continues Work to Understand Potential Impacts of Pharmaceuticals in
Water EPA is seeking comment on an Information Collection Request (ICR)
that will be used in a detailed study of unused pharmaceutical disposal
methods by hospitals, long-term care facilities, hospices and veterinary
hospitals. EPA is seeking more information on the practices of the
health care industry to inform future potential regulatory actions, and
identify best management and proper disposal practices. This is one of
several actions the agency is taking to strengthen its understanding of
disposal practices and potential risks from pharmaceuticals in water. 

"The agency's work to increase industry stewardship and scientific
understanding of pharmaceuticals in water continues," said Benjamin H.
Grumbles, EPA's assistant administrator for water. "By reaching out to
the National Academy of Sciences and requesting information from the
health care industry, EPA is taking important steps to enhance its
efforts." 

The agency is also commissioning the National Academy of Sciences to
provide scientific advice on the potential risk to human health from low
levels of pharmaceutical residues in drinking water. The National
Academy of Sciences will convene a workshop of scientific experts Dec.
11-12, to advise the agency on methods for screening and prioritizing
pharmaceuticals to determine potential risk.

Other actions the agency is taking include: expanding a recent fish
tissue pilot study to sample nationally to determine whether residues
from pharmaceuticals and personal care products (PPCPs) may be present
in fish and waterways; developing a methodology to establish water
quality criteria to protect aquatic life; and conducting studies to
examine the potential occurrence of PPCPs in sewage sludge and
wastewater. To facilitate these efforts, the agency has developed
state-of-the-art analytical methods capable of detecting various
pharmaceuticals, steroids and hormones at very low levels.

EPA also is participating in an international effort with the World
Health Organization to study appropriate risk assessment methods for
pharmaceuticals as environmental contaminants. All these actions reflect
advice the agency sought from a broad range of stakeholders including
environmental and public health groups, drinking water and wastewater
utilities, state water and public health agencies, and the agricultural
community.

EPA?s four-pronged approach for PPCPs in water is aimed at strengthening
scientific knowledge; improving public understanding; building
partnerships for stewardship; and taking regulatory action when
appropriate. 

EPA will accept public comments on the Health Care Industry ICR for 90
days after it is published in the Federal Register.

More information on EPA?s research and response to PPCPs in the
environment: http://www.epa.gov/waterscience/ppcp/

 

_____________________________

Sierra E. Fletcher

Associate - Policy and Programs

Product Stewardship Institute, Inc.

137 Newbury Street, 7th Floor

Boston, MA 02116

617-236-4886 (phone)

617-859-9889 (fax)

sierra at productstewardship.us <mailto:scott at productstewardship.us> 

www.productstewardship.us <http://www.productstewardship.us/> 

 

-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://lists.dep.state.fl.us/pipermail/pharmwaste/attachments/20080812/10cb3015/attachment.html


More information about the Pharmwaste mailing list